Peter Siachos Joins Gordon & Rees’s New Jersey Office

Friday, June 7, 2013

Peter Siachos has joined the New Jersey and New York offices of Gordon & Rees as a partner in the Commercial Litigation, Franchise, Product Liability, and Hospitality Practice Groups. Having tried over 40 cases to conclusion, Mr. Siachos has comprehensive litigation experience representing major corporations, franchisors, closely-held businesses, partnerships, and individuals in multiple jurisdictions in a wide range of complex commercial disputes before federal and state trial and appellate courts, administrative and regulatory agencies, and alternative dispute resolution panels.

More >>

Tags:  Gordon Rees Scully Mansukhani, LLP

Skadden – Deutsche Bank Closes Financing for Brookfield Office Properties

Friday, June 7, 2013

Skadden represented Deutsche Bank AG as lead arranger and administrative agent for $1 billion in financing on two of the four office towers at Brookfield Place in Lower Manhattan (formerly known as the World Financial Center): the 2.5-million-square-foot 225 Liberty St. and the 1.8-million-square-foot 250 Vesey St., announced on June 3.

More >>

Tags:  Skadden, Arps, Slate, Meagher & Flom LLP | New York

Davis Polk – General Electric Capital Corporation $1 Billion Preferred Stock Offering

Friday, June 7, 2013

Davis Polk advised Barclays Capital Inc., Citigroup Global Markets Inc., Goldman, Sachs & Co., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated and Morgan Stanley & Co. LLC as joint book-running managers in connection with the public offering of 10,000 shares of fixed-to-floating-rate non-cumulative perpetual preferred stock, Series C by General Electric Capital Corporation (“GECC”).

More >>

Tags:  Davis Polk & Wardwell LLP | New York

Davis Polk – Pfizer Inc. $4 Billion Notes Offering

Friday, June 7, 2013

Davis Polk advised underwriters represented by Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, Goldman, Sachs & Co. and RBS Securities Inc. in connection with the offering of $4 billion aggregate principal amount of notes issued by Pfizer Inc. The notes were offered in five tranches, one floating-rate tranche maturing in 2018 and four fixed-rate tranches maturing in 2017, 2018, 2023 and 2043.

More >>

Tags:  Davis Polk & Wardwell LLP | New York

Davis Polk – Concur Technologies, Inc. Convertible Senior Notes Offering

Friday, June 7, 2013

Davis Polk advised Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC as representatives of the initial purchasers in connection with a Rule 144A offering by Concur Technologies, Inc. of an aggregate principal amount of $488.75 million of its 0.5% convertible senior notes due 2018, which included $63.75 million aggregate principal amount of notes from the full exercise of the initial purchasers’ over-allotment option. In addition, Davis Polk advised Deutsche Bank AG, UBS AG, Credit Suisse International and JPMorgan Chase Bank, National Association as counterparties to convertible note hedge and warrant transactions in connection with the offering.

More >>

Tags:  Davis Polk & Wardwell LLP | Silicon Valley

Davis Polk – Meritor, Inc. Concurrent Notes Offering and Cash Tender Offer

Friday, June 7, 2013

Davis Polk advised underwriters represented by Citigroup Global Markets, Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, RBS Securities Inc. and UBS Securities LLC in connection with an SEC-registered offering by Meritor, Inc. of $275 million of its 6.75% notes due 2021. Davis Polk also advised Citigroup Global Markets Inc. as the dealer manager in connection with a concurrent cash tender offer by Meritor for any and all of its outstanding 8.125% notes due 2015. A portion of the net proceeds of the above-mentioned notes offering was used to pay the tender offer consideration, and the remainder is to be used for general corporate purposes.

More >>

Tags:  Davis Polk & Wardwell LLP | New York